JUDGMENT :

1. The dispute in this suit stands settled between the parties vide Settlement Agreement dated 17th January 2023 executed under the aegis of the Delhi High Court Mediation and Conciliation Centre. A copy of the agreement has been placed on record. Learned Counsel for the plaintiff and the defendant are present in Court.

2. The terms of the settlement, as set out in the aforesaid Settlement Agreement, read thus :

“1. That Second Party hereby recognizes and acknowledges the First Party's exclusive proprietary rights in the trademark OMEZ and not to challenge First Party's statutory and proprietary rights directly or indirectly at any time in future in India and globally.

2. The Second Party, their directors, confirm and undertake that they have stopped manufacturing, exporting, and offering for sale, advertising, directly or indirectly medicinal and pharmaceutical preparations not limited to tablets, capsules, injections, syrups under the mark OMEZ both for domestic sale in India and for export. The Second Party confirms that the last batch of OMEZ products manufactured an